Evidence map›Paper›PMID 24781861›Full record

ArticlePloS one2014

Fasting blood glucose--a missing variable for GFR-estimation in type 1 diabetes?

Petter Bjornstad, R Brett McQueen, Janet K Snell-Bergeon, David Cherney, Laura Pyle, Bruce Perkins, Marian Rewers, David M Maahs

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. The Gomez' equations and renal hemodynamic function in kidney disease research.American journal of physiology. Renal physiology · 2016
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Early diabetic nephropathy in type 1 diabetes: new insights.Current opinion in endocrinology, diabetes, and obesity · 2014
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Petter BjornstadDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
R Brett McQueenUniversity of Colorado School of Pharmacy, Aurora, Colorado, United States of America.
Janet K Snell-BergeonDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
David CherneyDepartment of Medicine, Division of Nephrology, Toronto General Hospital, University of Toronto, Ontario, Canada.
Laura PyleDepartment of Biostatistics, University of Colorado Denver, Aurora, Colorado, United States of America.
Bruce PerkinsDepartment of Medicine, Division of Endocrinology, Mount Sinai Hospital, University of Toronto, Ontario, Canada.
Marian RewersDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
David M MaahsDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado, United States of America; Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, Colorado, United States of America.
University of Colorado Denver · USToronto General Hospital · CAUniversity of Toronto · CA

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI KOSMISKI, LISA A. · 1985 to 2008
$52.6M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTERP30DK057516 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HUTTON, JOHN C · 2000 to 2010
$14.0M
SUBCLINICAL HEART DISEASE IN INSULIN-DEPENDENT DIABETESR01HL061753 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J. · 1999 to 2007
$5.2M
Complications and Comorbidities of Type 1 DiabetesR01HL113029 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI SNELL-BERGEON, JANET KATHLEEN · 2013 to 2016
$2.9M
Determinants of Accelerated CVD in Type 1 DiabetesR01HL079611 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J. · 2004 to 2007
$2.3M
NCATS NIH HHS UL1 TR001082NCRR NIH HHS M01 RR000051NCRR NIH HHS M01-RR00051NHLBI NIH HHS HL79611NHLBI NIH HHS R01 HL061753NHLBI NIH HHS R01 HL079611NHLBI NIH HHS R01 HL113029NHLBI NIH HHS R01 HL61753NIDDK NIH HHS P30 DK057516NIDDK NIH HHS P30 DK57516
6 · The paper itself

Abstract

objectiveEstimation of glomerular filtration rate (eGFR) is one of the current clinical methods for identifying risk for diabetic nephropathy in subjects with type 1 diabetes (T1D). Hyperglycemia is known to influence GFR in T1D and variability in blood glucose at the time of eGFR measurement could introduce bias in eGFR. We hypothesized that simultaneously measured blood glucose would influence eGFR in adults with T1D.

methodsLongitudinal multivariable mixed-models were employed to investigate the relationships between blood glucose and eGFR by CKD-EPI eGFRCYSTATIN C over 6-years in the Coronary Artery Calcification in Type 1 diabetes (CACTI) study. All subjects with T1D and complete data including blood glucose and cystatin C for at least one of the three visits (n = 616, 554, and 521, respectively) were included in the longitudinal analyses.

resultsIn mixed-models adjusting for sex, HbA1c, ACEi/ARB, protein and sodium intake positive associations were observed between simultaneous blood glucose and eGFRCYSTATIN C (β±SE:0.14±0.04 per 10 mg/dL of blood glucose, p<0.0001), and hyperfiltration as a dichotomous outcome (OR: 1.04, 95% CI: 1.01-1.07 per 10 mg/dL of blood glucose, p = 0.02).

conclusionsIn our longitudinal data in subjects with T1D, simultaneous blood glucose has an independent positive effect on eGFRCYSTATIN C. The associations between blood glucose and eGFRCYSTATIN C may bias the accurate detection of early diabetic nephropathy, especially in people with longitudinal variability in blood glucose.

Indexed as

Glomerular Filtration RateAdultBlood GlucoseCohort StudiesCystatin CDiabetes Mellitus, Type 1Diabetic NephropathiesFastingFemaleHumansMaleMiddle AgedRisk FactorsVascular CalcificationYoung AdultBlood GlucoseCystatin C

Identifiers

PMID24781861
PMCPMC4004575
OpenAlexW2068213275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.